News Releases

08.16.2024

Ultrasound propulsion reduces relapse rate incidence by 70% in patients with post-lithotripsy residual fragments as shown in the University of Washington randomized controlled trial published in Journal of Urology (Article PDF, Urology Times Interview)

08.16.2024

Best Endourology/Stone Paper – University of Washington’s “Randomized Controlled Trial of Ultrasonic Propulsion–Facilitated Clearance of Residual Kidney Stone Fragments vs Observation” highlighted as the best paper in Stone Disease at the World Congress of Endourology 2024 conference.

04.10.2024

Come visit the SonoMotion booth at the American Urological Association conference in San Antonio, TX on May 3-5, 2024 (Booth #1222).

04.08.2024

Best of EAU24 Abstracts – SonoMotion’s Break Wave First-In-Human clinical results to be featured at the EAU24 plenary session “Best of EAU24 Abstracts: An expert discussion” on Monday, April 8, 2024.

04.05.2024

Strong presence at the European Association of Urology conference with two Break Wave presentations, including (i) First-In-Human clinical trial results by Dr. Ben Chew and (ii) “Advances in technology – Burst-wave lithotripsy: All set?” by Dr. Mehmet Özsoy.

10.18.2023

SonoMotion initiates Break Wave pivotal trial (SOUND) at ten sites in the United States and Canada.